A detailed history of Atwater Malick LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Atwater Malick LLC holds 1,552 shares of MRK stock, worth $198,221. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,552
Holding current value
$198,221
% of portfolio
0.07%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$113.24 - $131.95 $175,748 - $204,786
1,552 New
1,552 $204,000
Q4 2019

Jan 07, 2020

SELL
$77.58 - $87.54 $52,754 - $59,527
-680 Closed
0 $0
Q3 2019

Oct 15, 2019

BUY
$76.08 - $82.93 $51,734 - $56,392
680 New
680 $57,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Atwater Malick LLC Portfolio

Follow Atwater Malick LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Atwater Malick LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atwater Malick LLC with notifications on news.